Continuous ambulatory peritoneal dialysis in diabetics with end-stage renal disease

The New England Journal of Medicine
P AmairD Oreopoulos

Abstract

Twenty diabetics with end-stage renal disease who had never previously received dialysis treatment were treated with continuous ambulatory peritoneal dialysis for periods of two to 36 months (average, 14.5). Intraperitoneal administration of insulin achieved good control of blood sugar. Even though creatinine clearance decreased significantly (P = 0.001), control of blood urea nitrogen and serum creatinine was adequate. Hemoglobin and serum albumin levels increased significantly (P = 0.005 and 0.04, respectively). Similarly, there was a significant increase in serum triglycerides and alkaline phosphatase (P = 0.02 and 0.05). Blood pressure became normal without medications in all but one of the patients. Retinopathy, neuropathy, and osteodystrophy remained unchanged. Peritonitis developed once in every 20.6 patient-months--a rate similar to that observed in nondiabetics. The calculated survival rate was 93 per cent at one year; the calculated rate of continuation on ambulatory peritoneal dialysis was 87 per cent. We conclude that continuous ambulatory dialysis with intraperitoneal administration of insulin is a good alternative treatment for diabetics with end-stage renal disease.

References

Nov 1, 1979·Diabetologia·F C Goetz, C M Kjellstrand
Oct 1, 1979·Annals of Surgery·J S NajarianB G Sommer
Jan 1, 1979·Transactions - American Society for Artificial Internal Organs·C T Flynn, J A Nanson
Apr 2, 1981·The New England Journal of Medicine·R FlückigerK H Gabbay
May 1, 1981·Diabetes Care·M L ReevesC M Peterson
Jun 10, 1980·Clinica Chimica Acta; International Journal of Clinical Chemistry·W D Hankins, L Holladay
Jun 1, 1980·Diabetologia·M J de BoerA F Casparie

❮ Previous
Next ❯

Citations

Sep 1, 1993·Muscle & Nerve·L H Phillips, F H Williams
Oct 1, 1988·Pediatric Nephrology : Journal of the International Pediatric Nephrology Association·B S BeckmanJ W Fisher
Jun 1, 1986·World Journal of Surgery·R J RohrerA P Monaco
Jan 1, 1987·The Journal of Diabetic Complications·F CoronelA Barrientos
Mar 18, 1982·The New England Journal of Medicine·J T Harrington
Jun 30, 1983·The New England Journal of Medicine·R G Luke
Jan 1, 1992·Journal of Medical and Veterinary Mycology : Bi-monthly Publication of the International Society for Human and Animal Mycology·B MorrisA Woodgyer
Mar 28, 2009·Radiographics : a Review Publication of the Radiological Society of North America, Inc·Sam StuartAnmol Malhotra
Jan 1, 1986·Intensive Care Medicine·A Grenfell
Jul 24, 1982·Lancet·R C George, M S Shafi
Jun 1, 1989·American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation·W D MatternM A Khayrallah
May 1, 1989·American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation·B PirainoM Sorkin
Feb 1, 1993·American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation·L F SaldanhaH C Gonick
Sep 1, 1983·American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation·C M BunkeF C Luft
Jan 1, 1983·Kidney International·S I Vas
May 1, 1982·Kidney International·E A Friedman
Jan 25, 2008·American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation·Martin SedlacekClay A Block
Sep 11, 2007·Infectious Disease Clinics of North America·Smita GuptaNancy Khardori
Jan 1, 1987·The Journal of Diabetic Complications·N GrefbergC Berne
Feb 6, 2008·Diabetes, Obesity & Metabolism·Pedro Iglesias, Juan J Díez
Jan 1, 1989·The Journal of Diabetic Complications·R Khanna, D G Oreopoulos
Jan 1, 1983·The Diabetes Educator·E Stephenson, T Nordberg
May 15, 1998·JPEN. Journal of Parenteral and Enteral Nutrition·J M MoránL M Vinagre
Jan 1, 1992·Scandinavian Journal of Urology and Nephrology·E ReissellJ Ahonen
Feb 1, 1986·Drug Intelligence & Clinical Pharmacy·R R BerardiM L Hyneck
Nov 1, 1983·Postgraduate Medicine·C A Verdonk
May 16, 1983·Klinische Wochenschrift·S PeterU Binswanger
Apr 11, 2020·Seminars in Dialysis·Jeffrey H WilliamSylvia E Rosas
Jan 1, 1989·Diabetic Medicine : a Journal of the British Diabetic Association·F BerisaJ Michael
May 11, 2021·Peritoneal Dialysis International : Journal of the International Society for Peritoneal Dialysis·Peter G BlakeRebecca Cooper
Mar 1, 1996·Current Problems in Surgery·M B AdamsA M Roza

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.